TRPV1 expression in acupuncture points: response to electroacupuncture stimulation.
The present study was to examine the distribution of transient receptor potential vanilloid type-1 (TRPV1) receptor immunoreactivity in the acupuncture points (acupoint), and determine the influences of electroacupuncture (EA) stimulation on TRPV1 expression. EA stimulation of BL 40 was conducted in two sessions of 20 min separated by an 80 min interval in anesthetized rats. Sections of skin containing BL 40, and its non-meridian control were examined by immunolabeling with antibodies directed against TRPV1. Without EA, the number of subepidermal nerve fibers expressing TRPV1 was higher in the acupoint than in non-acupoint control skin (p<0.01). The subepidermal nerve fibers showed the co-localization of TRPV1 with peripherine, a marker for the C-fibers and A-δ fibers. The expression of TRPV1 in nerve fibers is significantly increased by EA stimulation in acupoints (p<0.01). However the upregulation in the non acupoint meridian and the non-meridian control skin was short of statistical significance. Double immunostaining of TRPV1 and neuronal nitric oxide synthase (nNOS) revealed their co-localization in both the subepidermal nerve fibers and in the dermal connective tissue cells. These results show that a high expression of TRPV1 endowed with nNOS in subepidermal nerve fibers exists in the acupoints and the expression is increased by EA. We conclude that the higher expression of TRPV1 in the subepidermal nerve fibers and its upregulation after EA stimulation may play a key role in mediating the transduction of EA signals to the CNS, and its expression in the subepidermal connective tissue cells may play a role in conducting the local effect of the EA.
Department of Obstetrics and Gynecology, David Geffen School of Medicine at University of California at Los Angeles, Harbor-UCLA Medical Center, Torrance, CA 90502, USA.
Therese S
TS
Abraham
Ming-Liang
ML
Chen
Sheng-Xing
SX
Ma
D015669:Acupuncture Points; D000818:Animals; D020405:Dermis / Q000378:metabolism; D015671:Electroacupuncture / Q000379:methods*; D006801:Humans; D007150:Immunohistochemistry; D007381:Intermediate Filament Proteins / Q000378:metabolism; D008297:Male; D008562:Membrane Glycoproteins / Q000378:metabolism; D009413:Nerve Fibers, Myelinated / Q000378:metabolism; D036421:Nerve Fibers, Unmyelinated / Q000378:metabolism; D009419:Nerve Tissue Proteins / Q000378:metabolism; D019001:Nitric Oxide Synthase / Q000378:metabolism; D052248:Nitric Oxide Synthase Type I; D064531:Peripherins; D051381:Rats; D017207:Rats, Sprague-Dawley; D050916:TRPV Cation Channels / Q000096:biosynthesis*
D007381:Intermediate Filament Proteins; D008562:Membrane Glycoproteins; D009419:Nerve Tissue Proteins; D064531:Peripherins; D050916:TRPV Cation Channels; C494484:TRPV1 receptor; D019001:Nitric Oxide Synthase; D052248:Nitric Oxide Synthase Type I; C496322:Nos1 protein, rat
Neuroscience. 2000;100(4):685-8
11036202
Eur J Pharmacol. 2004 Oct 1;500(1-3):351-69
15464045
Curr Mol Pharmacol. 2008 Nov;1(3):255-69
20021438
Acupunct Electrother Res. 1994 Jan-Mar;19(1):3-9
7916175
J Invest Dermatol. 2004 Aug;123(2):410-3
15245445
Anesth Analg. 1998 Nov;87(5):1129-34
9806695
BMJ. 1996 Feb 24;312(7029):485-8
8597683
Nature. 1997 Oct 23;389(6653):816-24
9349813
Exp Dermatol. 2004 Mar;13(3):129-39
14987252
Exp Physiol. 2002 Mar;87(2):239-244
29345433
J Comp Neurol. 2003 Oct 6;465(1):121-35
12926020
Trends Pharmacol Sci. 2000 Feb;21(2):41-2
10664603
Annu Rev Neurosci. 2001;24:487-517
11283319
J Invest Dermatol. 1998 Jan;110(1):1-7
9424078
Neurosci Lett. 2002 Feb 15;319(2):87-90
11825677
Mol Cell Neurosci. 2000 Apr;15(4):331-42
10845770
Brain Res Mol Brain Res. 1998 May;56(1-2):89-98
9602075
Zhen Ci Yan Jiu. 1996;21(3):68-70
9387346
Life Sci. 1995;56(22):1845-55
7746093
J Neurocytol. 2004 May;33(3):321-9
15475687
Acta Otolaryngol. 2004 May;124(4):515-9
15224886
Acupunct Electrother Res. 1989;14(2):115-20
2575342
Zhen Ci Yan Jiu. 1987;12(4):278-84, 277
3127081
Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3655-60
10725386
J Neurophysiol. 2003 Aug;90(2):780-5
12672780
Nature. 1999 Jul 29;400(6743):452-7
10440374
Brain Res. 2000 Feb 7;855(1):124-31
10650138
Blood. 1998 Feb 15;91(4):1332-40
9454764
Toxicol Appl Pharmacol. 1999 Jan 1;154(1):106-15
9882597
J Biol Chem. 2005 Jan 7;280(1):618-27
15513920
Blood. 2004 Jul 15;104(2):462-9
15044250
Am J Chin Med. 1998;26(1):13-8
9592589
Brain Res. 2005 Mar 10;1037(1-2):70-7
15777754
Brain Res. 2004 Feb 13;998(1):130-5
14725976
Br J Pharmacol. 2000 Jan;129(2):227-30
10694225
Br J Dermatol. 2006 Nov;155(5):970-6
17034527
Br J Pharmacol. 1999 Sep;128(2):428-34
10510454
Neuroscience. 2002;109(4):787-98
11927161
Neurosci Lett. 2009 Jan 16;449(3):173-7
19013501
Brain Res. 2003 Feb 14;963(1-2):190-6
12560124
J Altern Complement Med. 2003 Apr;9(2):207-15
12804074
Neuron. 1998 Sep;21(3):531-43
9768840
Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13396-401
11606761
Neurosci Lett. 1998 Jul 10;250(3):177-80
9708861
Eur J Neurosci. 1999 Mar;11(3):946-58
10103088
Pain. 1996 Dec;68(2-3):195-208
9121806
Brain Res. 2003 Aug 8;980(2):293-6
12867271
Auton Neurosci. 2005 Mar 31;118(1-2):93-101
15795182
Trends Pharmacol Sci. 2001 Jul;22(7):346-9
11431028